Canada markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2113-0.0067 (-3.07%)
At close: 04:00PM EDT
0.2144 +0.00 (+1.47%)
After hours: 06:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
7,847
14,096
9,300
9,805
5,062
Selling General and Administrative
4,711
4,770
5,967
4,681
4,393
Total Operating Expenses
12,558
18,865
15,267
14,486
9,455
Operating Income or Loss
-12,558
-18,865
-15,267
-14,486
-9,455
Interest Expense
6.953
13.805
7.027
9.285
3.264
Income Before Tax
-12,565
-18,851
-15,274
-14,495
-9,458
Income from Continuing Operations
-12,565
-18,851
-15,274
-14,495
-9,458
Net Income
-12,565
-18,851
-15,274
-14,495
-9,458
Net Income available to common shareholders
-12,565
-18,851
-15,274
-14,495
-9,458
Basic EPS
-7.60
-
-11.22
-16.50
-17.10
Diluted EPS
-7.60
-
-11.22
-16.50
-17.10
Basic Average Shares
2,867
-
1,362
878.443
553.948
Diluted Average Shares
2,867
-
1,362
878.443
553.948